Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
View/Download PDF

Translate this page into:

Original Article
13 (
01
); 051-056
doi:
10.1055/s-0042-1757557

Marching Ahead through the Pandemic: Continuing Anesthesia Services in COVID Era—Our Experience from a Tertiary Care Cancer Centre

Department of Onco-Anaesthesia and Palliative Medicine, National Cancer Institute, All India Institute Of Medical Sciences, New Delhi, India
Department of Onco-Anaesthesia and Palliative Medicine, BRAIRCH, All India Institute Of Medical Sciences, New Delhi, India

*Corresponding author: Sushma Bhatnagar, MBBS, MD, Room no. 242, BRAIRCH, All India Institute Of Medical Sciences, New Delhi 110029, India. sushmabhatnagar1@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Abstract

Swati Bhan
FI21120725-1 Swati Bhan

Introduction This paper aims to provide an overview of the administrative and clinical preparations done in a tertiary care cancer hospital in continuing operation theatre (OT) services through the COVID pandemic.

Methods Retrospective data collection, data for the past 1.5 years (COVID period) March 2020 to August 2021 were compared to surgical output for a similar duration of time before the COVID era (September 2018–February 2020).

Results A total of 1,022 surgeries were done under anesthesia in the COVID period as against 1,710 surgeries done in a similar time frame in the pre-COVID era. Overall, we saw a 40%drop in the total number of cases. Thorax, abdominal, and miscellaneous surgeries (soft tissue sarcomas, urology, and gyneconcology) saw a maximum fall in numbers; however, head and neck cases saw an increase in numbers during the pandemic. Surgical morbidity and mortality were similar in the COVID and pre-COVID era. No cases of severe COVID infection were reported among the healthcare staff working in OT.

Discussion We could successfully continue our anesthesia services with minimal risk to healthcare staff throughout the pandemic by adopting major guidelines in a pragmatic and practical approach with minor changes to suit our setup.

Keywords

PubMed

Introduction

The COVID-19 pandemic has struck the world like a major thunderstorm, diverting all the medical attention and resources in managing this disease of unprecedented proportions. The world has dealt with two major waves of this disease with some countries experiencing a third or fourth wave in the form of newer more virulent mutant strains.1 The large number of COVID cases needing intensive care unit (ICU) care and hospitalization overwhelmed the healthcare services worldwide,23 this led to most hospitals being able to care only for COVID patients and the normal health services being heavily restricted. The lockdowns in various states restricted patient movement and compounded this problem and lead to further delays in non-COVID patients seeking treatment.45

Cancer is unique among the non-COVID illness as it requires a time-bound treatment in the form of surgical resection or chemo-radiotherapy, and any delays in treatment will lead to cancer progressing into an unresectable or incurable state.6 Diversion of health care facilities into COVID care and lockdown restricting patient movement are some harsh realities delaying treatment in a time-sensitive disease such as cancer, which is being faced by countries across the world.7 There seems to be no immediate end to this pandemic with the emergence of newer mutant variants of the virus and breakthrough increase in cases8; thus, the need of the hour is that each healthcare organization should come up with steps and guidelines to continue care for non-COVID patients and chronic diseases.

This paper aims to provide an overview of the administrative and clinical preparations done in a tertiary care cancer hospital in continuing emergency operation theatre (OT) services, resuming anesthesia services in the waning phases of the pandemic, and continuing care for cancer patients needing surgery. Through our experience and patient data, we aim to provide a framework for the preparation and continuity of cancer patient care in this COVID era with an emphasis to highlight our manpower management and infection control practices for the safe conduct of anaesthesia in this era of an ongoing pandemic.

Methodology

We undertook a retrospective data collection of all surgical cases done at our institute from the start of the pandemic and compared it to the surgical output from a similar time frame in the pre-COVID era. Data for the past 1.5 years where COVID peaked in the form of two waves were collected starting from March 2020 to August 2021; these were compared to surgical output for a similar duration of time before the COVID era (18 months–September 2018 to February 2020) to get a comparative idea of our work with the pre-COVID era. Data were tabulated and analyzed for demographic parameters such as age group and sex distribution of patients undergoing surgery. Surgical procedures were segregated and tabulated according to the operating specialty. Surgical morbidity in the form of Clavien–Dindo score was recorded; length of ICU stay, length of hospital stay, major surgical morbidity, and overall mortality were recorded. The major surgical morbidity was defined as Clavien–Dindo score of more than 3. The incidence of COVID positivity among healthcare staff was also noted.

Results

A total of 1,022 surgeries were done under anesthesia from March 2020 to August 2021 as against 1,710 surgeries done in a similar time frame in the pre-COVID era (September 2018–February 2020). The basic patient demographics and the American Society of Anesthesiologists (ASA) physical status are tabulated in Table 1. The number of patients operated under each surgical specialty with the type of anaesthesia given is tabulated in Table 2. The main anaesthesia and surgical outcomes are shown in Table 3, and the incidence of COVID positivity among health care staff is charted in Table 4.

Table 1
Basic patient demographics and baseline physical status

Parameter

Patients – number (percentage)

March 2020-August 2021

September 2018–February 2020

Total cases in major OT

1022

1710

Routine:emergency

889:133 (86.98:13.02)

1385:325 (81:19)

Male:female

684:338

1043:667

ASA physical status

 • 1

715 (69.96)

1094 (63.97)

 • 2

255 (24.95)

496 (29)

 • 3

41 (4.01)

111 (6.49)

 • 4

11 (1.07)

9 (0.52)

Age group

  < 40

296 (28.96)

547 (31.98)

 40-59

531 (51.95)

923 (53.97)

 60-79

174 (17.02)

231 (13.5)

  > 80

21 (2.05)

9 (0.52)

Upfront resections: preop RT/NACT

603:419 (59:41)

1146:564 (67:33)

Minor OT (ICRT)

134

430

Table 2
Types of surgeries

Type of surgery

March 2020 -August 2021

September 2018–February 2020

Percentage change

Head and neck

345

340

+1%

Breast

328

530

−38%

Thorax

38

130

−79%

Abdominal

225

508

−55.7%

Miscellaneous

86

202

−81.88

Total

1022

1710

40.24%

Table 3
Anesthesia and surgical outcomes

Parameter

March 2020 -August 2021 patient number (percentage)

September 2018–February 2020 patient number (percentage)

COVID positivity

97 (9.49)

0

Shifted to ICU in the postoperative period

501 (49.02)

569 (33.27)

Length of ICU stay (days)

 • 1

726 (72)

1299 (76)

 • 2

123 (12)

154 (9)

 • 3

112 (10.9)

137 (8)

 • >3

51 (5)

120 (7)

Clavien–Dindo 3, 4

21 (2.05)

31 (1.81)

Length of hospital stay (days)

 • <5

531 (51.95)

940 (54.97)

 • 5-10

388 (37.96)

591 (34.56)

 • 10-15

92 (9)

154 (9)

 • >15

11 (1.07)

25 (1.46)

Mortality

15 (1.46)

20 (1.16)

Table 4
The incidence of COVID 19 among OT staff

Healthcare worker

Numbers

Onco-anesthesia residents and faculties.

23

Nursing staff

77

Operation theater assistants

11

Sanitation staff

38

Total

149

Mortality/severe disease

0

As seen by our data, anesthesia services were curtailed due to restrictions in cancer surgeries in this pandemic. Overall, we saw a 40% drop in the total number of cases. Thorax, abdominal, and miscellaneous surgeries (soft tissue sarcomas, urology, and gyneoncology) saw a maximum fall in numbers; however, head and neck cases saw an increase in numbers during the pandemic (Table 2). Intracavitary radiotherapy (ICRT) procedures for carcinoma cervix also saw a sharp fall of 69% (134 vs. 430 cases).

The percentage of post-operative major morbidity (Clavien–Dindo 3, 4) and mortality remained similar in the COVID period (Table 3). As per surgical guidelines,9 patients with curative intent for cancer resections were taken on a priority to minimize delay in treatment; thus, head and neck cancer resections and breast surgeries saw the maximum numbers being operated (Table 3).

As seen in Table 4, we detected 149 COVID cases among the doctors and healthcare staff working in the OT. However, no cases of severe disease were reported among the staff.

Discussion

Our hospital, a 182-bedded cancer center in a tertiary care institute, witnessed an unprecedented crisis of inpatient care as the focus of immediate concern was managing COVID patients. We took several steps to tweak and redesign our infrastructure to continue emergency surgeries throughout the pandemic and restarted elective OTs as the situation permitted. At the onset of the pandemic and lockdowns, OT services were abruptly halted (March 2020); elective surgeries were resumed in three phases. To restart elective surgeries, 20 beds out of the 46 designated surgical beds were converted into an isolation area for preoperative patients. As per our institutional practice, a disease management group (DMG) consisting of a surgical oncologist, medical oncologist, and radiation oncologist charted the treatment plan of every patient in the OPD. Patients decided for surgical intervention in the DMG were then triaged by the surgical team for the timing of surgery. A basic triaging policy depending on the nature of malignancy was followed in resuming elective cases. In the first phase (May 2020), simple surface malignancies (breast, soft tissue tumors) with no comorbidities were posted for surgery. In the second phase (June-July 2022), moderately complex surgical procedures (head and neck, colorectal, and gastric surgeries) were posted. In the third phase (August 2020 onward), complex surgical procedures such as thoracic and hepatobiliary surgeries were started.

Various society and organizational guidelines were1011 used as guiding forces to formulate work plans and alter clinical practices to protect the healthcare staff. The basic steps undertaken by us and the practical challenges faced in the ground-level implementation of various guidelines12 are summarized and can be discussed under the following headings.

  • Preparation of OTs and setting up infection control protocols.

  • Preoperative patient evaluation and optimization.

  • Tweaks in anesthesia practices and equipment.

  • Postoperative anesthesia care.

  • Disinfection practices and healthcare worker screening.

Preparation of Operation Theatres and Setting up of Infection Control Protocols

What the guidelines suggest – Summary of major guidelines for infection control13 suggests screening for symptoms of COVID patients and attendants on arrival in hospital, COVID testing (RT-PCR-based) before surgery, and extensive use of masks for the patient in the perioperative period. For OT, preparation of both Indian1012 and international guidelines1114 suggested that a separate operating room with its ventilation system and a designated high-efficiency particulate air (HEPA) filter system be used as an OT for COVID-positive patients, high frequency of air changes (25/h) to minimize viral load is suggested in other OTs dealing with non-COVID patients.14

Our practice –As COVID cases reduced, elective OTs were gradually resumed. Our basic steps to prepare OT services infrastructure with COVID care were as follows:

  • Social distancing with a minimum distance of 6 feet between beds was done and only a single attendee found asymptomatic at the screening was allowed to be with the patient during the perioperative period.

  • A separate isolation chamber with adequate distancing between beds was made functional, a patient admitted for surgery was given a bed here, RT-PCR for COVID was sent and the patient was kept in this area until an RT-PCR report was available. After the negative report, the patient was shifted to the preoperative ward and from there the patient was taken into the OT. Patients when called up for the admission were screened telephonically for symptoms of COVID or any recent contact with a positive case. We avoided outside testing before admission and all RT-PCR tests were sent after admission; this was done as an institutional policy to minimize the financial burden on patients.

  • The patient was taken for surgery within 48 hours of the negative report, i.e., as per the surgical list, most patients were operated the very next day of the negative report, in case of pending cases, patients were included in the list for the next day and thus were operated within 48 hours of the negative report.

  • In rare postponed cases beyond 48 hours of a negative report, repeat COVID testing was done.

  • A separate ward was designated as a postoperative ward and patients were shifted from the OT to this ward. From hereafter the postoperative stay patient was discharged. Thus, the one-way movement of a patient from admission to discharge was ensured.

  • Separate donning and doffing rooms were created in the OT complex and separate entry-exit routes were used to ensure one-way movement of health care staff.

Preoperative Patient Evaluation and Optimization

What literature suggests – The main guidelines11 for the conduct of anesthesia in the COVID setting suggest minimal contact with proper hand hygiene and barrier protections such as masks during preoperative patient evaluation.

Our practice – Social distancing was ensured in the pre anesthesia clinic (PAC). As the planned elective surgeries were restricted the footfall in the PAC dropped thus measures such as mandatory masks for patients and attendants, and an adequate distance between patient and doctor were easily implemented.

Routine preoperative assessment in the PAC clinic of a case with unknown COVID status (first visit, OPD patient) physical evaluation with auscultation, percussion, detailed airway examination, etc., was not done. Fitness was given on the basis of history, blood investigation, and radiology (chest X-ray reports). In the preoperative visit, a day before surgery of a patient with a COVID-negative report, detailed airway assessment, auscultation, and physical examination were done by the anesthetist as deemed necessary.

Routine preoperative tests such as pulmonary function tests and cardio-pulmonary exercise tests were stopped as these are potential aerosol-generation sources. In addition, we tried to introduce the concept of PAC follow-up over the phone via a dedicated department phone for PAC follow-ups after the initial visit to reduce repeated visits to the hospital.

Tweaks in Anaesthesia Practices and Equipment

Keeping in mind the guidelines suggesting the use of video laryngoscopes and minimizing aerosol generation procedures in the OT, we made the following changes to our practice:

  • Rapid sequence induction was used as a preferred modality of induction in nondifficult airway situations.

  • Video laryngoscope-guided intubation with a stylet tube and the most experienced anesthetist doing the procedure to ensure success in the first attempt in minimum time.

  • Direct cuff inflation and connection to anesthesia circuit before starting positive pressure ventilation.

  • Awake intubations were avoided, and an elective tracheostomy was planned in cases of an extremely difficult airway.

  • Supraglottic devices were avoided in the initial stage of the pandemic over concerns about aerosol generation due to leaks around the device; however, as the literature cleared the directions for their use,1516 second-generation devices (I-gel) were brought back into use.

  • Measures such as the proper fit of the SGD and insertion in a deep plane of anesthesia were taken to ensure minimal leaks. In cases where > 20% leak was detected the device was removed and the patient intubated.

  • Barrier methods such as transparent boxes were initially adopted as the guidelines suggested but they were stopped from use as the literature progressed and their use showed no benefit.17

  • HME filters were used in the inspiratory and expiratory limbs of the anesthesia circuit.

  • Extubation practices were changed to ensure minimal coughing and generation of aerosols.

  • For procedures under sedation or monitored anesthesia care, spontaneous respiration was allowed with oxygenation as required. However, high aerosol-generating methods of oxygenation such as high-flow nasal cannula, high-flow oxygen on non-rebreathing masks were not employed. Methods of oxygenation with minimum aerosolization such as low-flow oxygen via nasal prongs were used and barrier methods to prevent the spread of infection were employed at all times.

  • For procedures planned under regional anesthesia alone, regional anesthesia was used as necessary and methods of oxygen supplementation with minimal aerosolization, e.g., low-flow oxygen via nasal prongs were used. However, preoperative evaluation and COVID testing protocols were the same for cases under general anesthesia, regional anesthesia, or sedation and monitored care.

Postoperative Anesthesia Care

What guidelines suggest – Adequate distancing in the recovery rooms, use of masks by patients in the postoperative area, avoiding extubation in the postoperative area.

Our practice – We minimized the use of recovery rooms, only one or two patients were kept in the recovery to ensure distancing, and procedures such as extubation, were avoided. As seen by our data, we planned and sent every major case to the ICU for recovery/ventilation and extubation. In the ICU, we had adequate resources and could ensure appropriate practices.

Disinfection Practices and Healthcare Worker Screening

What guidelines suggest –Both international and national guidelines insist on hand hygiene, wearing of masks, at least a long-sleeved water-resistant gown with eye protection, N95 or equivalent mask for aerosol generation procedures such as intubation.10

Our practice –All personnel involved in intubation and extubation wore an HIV kit with eye shied and N95 masks throughout the case. A full protection PPE kit as used in COVID areas was used for all positive cases/emergency cases with unknown COVID status.

  • As seen the world over the use of plastics increased in the operation theatre, we tried to minimize this. No plastic covers were put over the workstations or monitors as our OT complex was regularly fumigated if a case came out positive.

  • Anesthesia circuits, soda-lime canisters, and disposables were changed after every case.

  • Disposables such as patient circuits, OT table sheets, syringes, etc., were changed after every case.

  • Single-use devices such as I-gel for ventilation or video laryngoscope with disposable blade (McGrath) for ease of use were increasingly put into practice.

All health care workers were regularly screened for symptoms, a symptomatic healthcare worker was immediately isolated and tested. The backup ansethesia team was kept if the main team was isolated in contact tracing with a case.

High-risk contacts with a case (more than 15 minute exposure or exposure from less than 1 meter or exposure without N95 mask, gown, and gloves) were isolated for the incubation period of the virus, i.e., 5 days, and then tested. As seen by our data (Table 4), these practices yielded results in the form of 149 OT staff testing positive but no severe case or mortality was seen.

Conclusion and Summary

As seen by our data and the description of our practices, by adopting major guidelines in a pragmatic and practical approach with minor changes to suit our setup, we could successfully continue our anesthesia services with minimal risk to our healthcare staff throughout the pandemic. Emergency services were continued throughout the pandemic, for elective cases, surgeries with a curative intent (head and neck cancer resections or early breast cancer) resection were continued on preference and other major surgeries were started as the pandemic waned.

As the pandemic progresses throughout the world and new variants of concern such as Omicron are being detected,8 we may expect further interruption of regular healthcare services in wake of rising cases with new variants. Thus, healthcare systems around the world especially in developing nations with resource constraints may use this document for micromanagement and implementation of anesthesia and infection control protocols to continue surgical and anaesthesia services in the era of this pandemic.

References

  1. Coronavirus Second Wave, Third Wave and Beyond: What Causes a COVID Surge. Accessed December 7, 2021 at:
    [Google Scholar]
  2. , , , , , , . Current burden on healthcare systems in low- and middle-income countries: recommendations for emergency care of COVID-19. Drugs Ther Perspect. 2020;36(10):466-468.
    [Google Scholar]
  3. , , , , . Disease and healthcare burden of COVID-19 in the United States. Nat Med. 2020;26(08):1212-1217.
    [Google Scholar]
  4. , . The untold toll - the pandemic's effects on patients without COVID-19. N Engl J Med. 2020;382(24):2368-2371.
    [Google Scholar]
  5. , , , , , , . Non-COVID neurological emergencies: a silent killer going unnoticed during COVID-19 pandemic. J Neurosci Rural Pract. 2021;12(03):461-469.
    [Google Scholar]
  6. , . COVID-19 and cancer: 1 year on. Lancet Oncol. 2021;22(04):411.
    [Google Scholar]
  7. , , , , , , . Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review. JCO Glob Oncol. 2021;7(07):311-323.
    [Google Scholar]
  8. , . (B.1.1.529): SARS-CoV-2 Variant of Concern. Accessed December 7, 2021 at:
    [Google Scholar]
  9. , , , et al . Indian expert opinion on cancer care during COVID-19 pandemic. South Asian J Cancer. 2021;10(01):9-18.
    [Google Scholar]
  10. , , , et al . All India difficult airway association (AIDAA) consensus guidelines for airway management in the operating room during the COVID-19 pandemic. Indian J Anaesth. 2020;64:S107-S115.
    [Google Scholar]
  11. , , , et al . Guidelines: anaesthesia in the context of COVID-19 pandemic. Anaesth Crit Care Pain Med. 2020;39(03):395-415.
    [Google Scholar]
  12. , , , et al . Society of Onco-Anesthesia and Perioperative Care (SOAPC) advisory regarding perioperative management of onco-surgeries during COVID-19 pandemic. Indian J Anaesth. 2020;64:S97-S102.
    [Google Scholar]
  13. , , , et al . Anaesthesia and COVID-19: infection control. Br J Anaesth. 2020;125(01):16-24.
    [Google Scholar]
  14. , , , et al . Preparing for a COVID-19 pandemic: a review of operating room outbreak response measures in a large tertiary hospital in Singapore. Can J Anaesth. 2020;67(06):732-745.
    [Google Scholar]
  15. , , . Supraglottic airways in the management of COVID-19 patients. Anaesth Crit Care Pain Med. 2020;39(05):589-590.
    [Google Scholar]
  16. , . ICM Anaesthesia COVID-19. Accessed September 26, 2021 at:
    [Google Scholar]
  17. , . FDA. Accessed December 7, 2021 at:
Show Sections